| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1997;30:603.)
© 1997 American Heart Association, Inc.
Articles |
From the Bioengineering and Chronobiology Laboratories, ETSI Telecomunicación, University of Vigo, Campus Universitario, Vigo (D.E.A., R.C.H., A.M., J.R.F.); and the Obstetrics and Gynecology Department, Hospital General Clínico Universitario de Galicia, Medical School, University of Santiago, Santiago de Compostela (M.I.), Spain.
| Abstract |
|---|
|
|
|---|
Key Words: blood pressure circadian rhythm pregnancy hypertension, gestational preeclampsia
| Introduction |
|---|
|
|
|---|
Changes in circadian variation of BP may be used either to predict preeclampsia or to assess its severity.14 Although reference values are now available for 24-hour ABPM in nonpregnant patients,10 11 15 only a few studies have been made of the normal pattern of ABPM in uncomplicated pregnancies,16 17 18 19 20 21 but without comparison with the circadian pattern of BP in complicated pregnancies, an issue only occasionally addressed.14 20 22 Against the background of reliance on casual BP measurements for the diagnosis of preeclampsia, the approach of (1) evaluating the circadian predictable variability in BP for both uncomplicated and complicated pregnancies by the use of portable, noninvasive, and fully automatic devices and (2) the proper processing by chronobiologic methods of the time series thus obtained can be useful in assessing early cardiovascular disease risk in pregnancy. We have used this approach to examine and compare characteristics of circadian variability in the BP of clinically healthy pregnant women as well as women with gestational hypertension and preeclampsia who were systematically monitored during their pregnancies.
| Methods |
|---|
|
|
|---|
BP Assessment
The SBP and DBP of each subject were automatically monitored
every 30 minutes during the day (9 AM to 10 PM)
and hourly during the night for 48 hours with an ABPM-630 Colin device
at the time of recruitment, and then every 4 weeks until delivery. BP
series were eliminated from analysis when they showed an
irregular schedule during the days of sampling, an odd sampling with
spans of more than 3 hours without BP measurement, or a night resting
span shorter than 6 hours or longer than 12 hours. The total number of
BP series provided by the women under investigation fulfilling all
mentioned requirements set a priori was 759. During sampling, all
women were living on their usual diurnal waking (
7:30 AM
to
12 PM for most subjects) and nocturnal resting
routine, following everyday life conditions with minimal restrictions.
They were told to follow a similar schedule during the days of sampling
and to avoid the use of medication for the duration of the trial. The
clinical evaluation of the monitor according to the standards published
by the Association for Advancement of Medical
Instrumentation23 has been previously
established.18 24 The BP cuff was worn on the nondominant
arm. ABPM was performed in addition to the womans routine antenatal
care, and no person was hospitalized during monitoring. Cuff size was
determined by upper arm circumference at the time of each visit. ABPM
always started between 10 AM and 1 PM. During
monitoring, each subject maintained a diary regarding information about
their activity cycle, dietary consumption, physical activity, emotional
state, and other external or internal stimuli possibly affecting
BP.
The Colin instrument uses both an oscillometric and an auscultatory (Riva Rocci-Korotkoff) method to assess BP. Since the oscillometric approach is usually more sensitive, there were fewer missing values (due to arm movement or environmental noise) with the oscillometric than auscultatory measurements. Moreover, when relying on the oscillometric measurements, the exact positioning of the cuff over the brachial artery is not critical. Consequently, a patient can take the cuff off, for example, to take a shower, exercise, or recharge the battery, and then replace it. The ability of the oscillometric technique to take accurate measurements in noisy environments and in the presence of a significant degree of respiration artifact is a further advantage. Therefore, the results reported here focus on the oscillometric measurements.
Statistical Methods
Original oscillometric data from each BP series were first
synchronized according to the rest-activity cycle of each individual by
recomputing all times of sampling in hours from bedtime to avoid
differences among subjects in actual times of daily activity and to
express results in circadian time rather than in less meaningful clock
hours. After synchronization, BP values were edited according to
commonly used criteria for the removal of outliers and measurement
errors.8 25 The remaining data were analyzed by
the use of Chronolab,26 a software package for biological
signal processing by linear and nonlinear least-squares estimation
that, among others, includes the single and population-mean
cosinor methods.27 Circadian
parameters were subsequently compared between groups of
women (complicated and uncomplicated pregnancies) in each trimester of
pregnancy, with a parameter test developed for comparison
of rhythm characteristics obtained from population-mean cosinor
analysis (Bingham test27 ).
| Results |
|---|
|
|
|---|
|
|
|
The elevation of SBP and DBP during the first trimester of pregnancy in subjects with a later diagnosis of gestational hypertension or preeclampsia compared with clinically healthy pregnant women is shown in Fig 1. This figure represents a circadian population chronogram (display of data as a function of time), with 2-hourly means and standard errors of data computed as follows: First, 2-hourly means are computed from each individual series, after stacking all data sampled during a 48-hour monitoring span in only one idealized 24-hour span (given the highly statistically significant rhythm with a period of 24 hours demonstrated in about 94% of all BP series studied). In a second step, the average of those individual means at each interval is computed averaging across the total number of series for any given population. The lower horizontal axis represents circadian time in hours after bedtime; the resting span is indicated by the dark bar in the lower horizontal axis. The cosine curve represented for each group corresponds to the best fitted model obtained by population-mean cosinor applied to all original BP values (not just to the 2-hourly means). The arrow from the upper horizontal axis indicates the circadian acrophase (lag from a defined reference time point of the crest time in the curve fitted to the data) for each group. The values of acrophase, in angular degrees, are computed taking bedtime as the circadian reference time point. Statistically significant differences between means for each group (detected by t test not adjusted for multiple testing) at any given interval are indicated by an asterisk above the lower horizontal axis. Differences in rhythm characteristics (as is the case here for the circadian MESOR and amplitude), as well as the general waveform of circadian variability in SBP and DBP, can be readily seen from this graphic representation. The characteristics of the circadian rhythm are represented in the tables below each chronogram. The tables also include information on the number of BP series analyzed for each group. The circadian rhythm characteristics given in the tables are provided only as a first approximation and for descriptive purposes, given the nonsinusoidal pattern of BP circadian variability as well as the different duration of the activity and resting spans.
Fig 2 represents the circadian chronograms of SBP (left) and DBP (right) of women sampled during the second trimester of pregnancy. The differences between normotensive subjects and women with gestational hypertension are highly statistically significant at all circadian times. The circadian MESOR of BP for normotensive pregnant women is statistically lower in the second as compared to the first trimester (P<.001 for both SBP and DBP). The decrease in BP cannot be demonstrated, however, for women with a final diagnosis of gestational hypertension or preeclampsia.
Fig 3, comparing SBP and DBP between healthy and complicated pregnancies sampled in the third trimester of gestation, is similar. Far away from the statistically significant difference in circadian MESOR between both groups documented by Bingham test, the 2-hourly means of SBP and DBP are statistically significantly higher in women with gestational hypertension or preeclampsia at all sampling times. Compared with the second trimester, BP slightly increases for normotensive pregnant women, reaching a circadian MESOR comparable to that computed in the first trimester for the same subjects (Fig 1). For women with complicated pregnancies, however, BP increases greatly from the second to the third trimester.
| Discussion |
|---|
|
|
|---|
Results from Fig 1 indicate a highly statistically significant difference in both SBP and DBP between complicated and uncomplicated pregnant women sampled during the first 14 weeks of gestation. The differences in BP are statistically significant at each and every one of the 2-hourly intervals in which the 24-hour span was divided for comparative analysis. The differences in BP are found several months before the actual clinical diagnosis of gestational hypertension is made (usually obtained well in advance of the third trimester of pregnancy). Moreover, the differences of about 11 mm Hg in the circadian MESOR of SBP and of about 6 mm Hg in DBP are found when both SBP and DBP for women with a later diagnosis of gestational hypertension or preeclampsia are well within the accepted normal physiologic range of BP variability.29 The circadian MESOR for the group of women with complicated pregnancies was 114.3/66.0 mm Hg for SBP/DBP; the 2-hourly means were always below 127/75 mm Hg for the same variables, far below the "normal" limit of 140/90 mm Hg. As in the first trimester, the highly statistically significant differences documented in the second trimester (Fig 2), exceeding 12 mm Hg in the circadian MESOR of SBP and 6 mm Hg in the circadian MESOR of DBP, are found with BP values well below 140/90 mm Hg, even for the hypertensive women. The documented differences in the circadian MESOR between healthy and complicated pregnant women sampled during the third trimester are of about 17 mm Hg for SBP and 9 mm Hg for DBP.
Figs 1 through 3 also show differences in circadian amplitude between healthy and complicated pregnancies in all trimesters of gestation. By the use of ABPM, several authors have found a reduced drop in BP at night in preeclamptic patients,30 31 whereas others report an inversion in the circadian pattern of BP associated with preeclampsia.14 22 32 However, Figs 1 and 2 indicate that, during the first and second trimesters of pregnancy, before the clinical diagnosis of disease for most women investigated, the circadian amplitude of BP is statistically higher in complicated pregnancies. An increase in circadian amplitude of BP before the actual onset of hypertension (elevation in circadian MESOR) was also noted in several previous studies.9 The circadian amplitude of BP is statistically higher in neonates with a family history of hypertension and cardiovascular disease as compared to those without such history.33 By 14 years of age, correlations are found between the circadian amplitude of DBP and target organ involvement, namely the thickness of the interventricular cardiac septum determined by M-mode echocardiography.34 Fig 3 indicates that in the third trimester of pregnancy, the difference in circadian amplitude of BP between the groups compared is still statistically significant. For the complicated-pregnancy women, the amplitude decreases significantly from the second to the third trimester. This is mainly due to the reduced drop in BP at night (and therefore reduced circadian amplitude) in the patients who developed preeclampsia. The differences in amplitude between healthy and complicated pregnancies in this last trimester stem from the lack of reduction in amplitude for the women who developed gestational hypertension but not preeclampsia. The difference in amplitude between these two groups of complicated pregnancies (gestational hypertension with or without proteinuria) is statistically significant in the third (P<.009 for both SBP and DBP) but not in the first or second trimesters (P>.121 in all cases). A decrease in circadian amplitude of BP could then provide useful information in the identification of those women with an elevated BP in pregnancy who could also develop proteinuria, an issue that needs further investigation in larger groups of women.
Despite the differences observed in Figs 1 through 3, diagnosis cannot rely on BP measurements obtained at any given individual circadian time. To illustrate this point, we focused the analysis of all BP values sampled between 10 AM and 1 PM, the usual timing of most scheduled visits of pregnant women to the obstetrician at Spanish hospitals, including our own setting. Fig 4 represents the frequency histograms of all values of SBP sampled between those hours in healthy (top) and complicated pregnancies (bottom) in each of the trimesters of pregnancy. The histograms indicate the high degree of overlap between the distributions of SBP values obtained for both groups of pregnant women. During the first trimester (Fig 4, left), there was a total overlap of 96.8% of all 1472 SBP values sampled between 10 AM and 1 PM (98.5% for mean arterial BP; 98.2 for DBP, not shown). Women who later developed clinically diagnosed gestational hypertension or preeclampsia had at those times SBP values as low as 80 mm Hg, with only 36 of a total of 408 SBP values actually exceeding 140 mm Hg. During the second trimester, BP actually decreases for healthy pregnant women but not for those who develop gestational hypertension.13 The degree of overlap in SBP is 97.3% (Fig 4, center); only 117 of the 1488 SBP values obtained from complicated pregnancies exceeded 140 mm Hg. Results were almost similar during the third trimester, when many pregnant women had already developed clinically diagnosed gestational hypertension or preeclampsia, characterized by a "clearly" elevated BP. The graph on the right of Fig 4, for the third trimester, indicates an overlap of 98.9% in SBP; only 287 of 1954 values sampled from pregnant women with gestational hypertension or preeclampsia exceeded 140 mm Hg.
|
The Table gives sensitivity and specificity based on BP values exceeding 140 or 110 or 90 mm Hg for SBP, mean arterial BP, and DBP, respectively. Results indicate a very poor sensitivity, comparable to that reported previously from other studies based on conventional casual BP sampling.1 2 3 4 5 6 Specificity is very high based on the distributions represented in Fig 4 and the chronograms of Figs 1 through 3: a very small number of BP samples actually exceeds the limit of 140/90 mm Hg for SBP/DBP, even in the third trimester, after the clinical diagnosis of gestational hypertension or preeclampsia has been made. One needs to be aware that results in the Table are overestimating the value of casual sampling and do not reflect the actual sensitivity of clinical diagnosis of gestational hypertension. The diagnosis indeed needs stronger criteria than just having one single value of BP obtained by ambulatory monitoring between 10:00 and 13:00 hours above 140 or 90 mm Hg for SBP or DBP.
|
This study represents an example of longitudinal monitoring in healthy and complicated pregnancies, keeping the everyday life conditions by the use of a fully ambulatory and noninvasive BP monitor. The results were based on 48-hour series rather than on the 24-hour profiles more currently obtained by ABPM.16 17 18 19 20 21 As a compromise with practicability, monitoring over 48 hours has been shown to present advantages.9 11 35 The individualized estimation of rhythm characteristics becomes more reliable; new end points are obtained, such as the circadian period, that cannot usually be estimated from 24-hour records. Moreover, there may be relatively large day-to-day changes in individual rhythm characteristics, due in part to differences in day-to-day schedules, that are at least partly accounted for by sampling over 2 or more days. Noninvasive ABPM combined with chronobiometric methods for analysis of sparse and nonequidistant time series offers new end points that allow an early assessment of the risk of gestational hypertension and preeclampsia.35
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received March 15, 1997; first decision April 17, 1997; accepted April 29, 1997.
| References |
|---|
|
|
|---|
2. Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R, Pelland N. A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol. 1985;151:191-196.[Medline] [Order article via Infotrieve]
3. OBrien WF. Predicting pre-eclampsia. Obstet Gynecol. 1990;75:445-452.[Medline] [Order article via Infotrieve]
4. Page EW, Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol. 1976;125:740-746.[Medline] [Order article via Infotrieve]
5. Reiss RE, OShaughnessy RW, Quilligan TJ, Zuspan FP. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Am J Obstet Gynecol. 1987;156:894-898.[Medline] [Order article via Infotrieve]
6. Villar MA, Sibai BM. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during the third trimester. Am J Obstet Gynecol. 1989;160:419-423.[Medline] [Order article via Infotrieve]
7. Halberg E, Delmore P, Finch M, Cornélissen G, Halberg F. Chronobiologic assessment of deviant human blood pressure: an invitation for improvements. In: Hayes DK, Pauly JE, Reiter RJ, eds. Chronobiology: Its Role in Clinical Medicine, General Biology, and Agriculture, Part A. New York, NY: Wiley-Liss; 1990;305-318.
8. Cornélissen G. Instrumentation and data analysis methods needed for blood pressure monitoring in chronobiology. In: Scheving LE, Halberg F, Ehret CF, eds. Chronobiotechnology and Chronobiological Engineering. Dordrecht, Netherlands: Martinus Nijhoff; 1987:241-261.
9. Cornélissen G, Haus E, Halberg F. Chronobiologic blood pressure assessment from womb to tomb. In: Touitou Y, Haus E, eds. Biologic Rhythms in Clinical and Laboratory Medicine. Berlin, Germany: Springer-Verlag; 1992:428-452.
10. Hermida RC, Ayala DE, Fernández JR, Mojón A. Time-specified reference limits for ambulatorily monitored blood pressure in clinical health. Biomed Instrum Technol. 1993;27:235-243.[Medline] [Order article via Infotrieve]
11. Hermida RC, Fernández JR. Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed Instrum Technol. 1996;30:257-266.[Medline] [Order article via Infotrieve]
12. Ayala DE, Hermida RC. Circadian time structure of cardiovascular characteristics in human pregnancy. Chronobiol Internat. 1993;10:128-136.[Medline] [Order article via Infotrieve]
13. Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia, I: predictable variability of cardiovascular characteristics during gestation in healthy and hypertensive pregnant women. J Perinatal Med. 1997;25:101-109.[Medline] [Order article via Infotrieve]
14. Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancy. Am J Obstet Gynecol. 1988;158:393-399.[Medline] [Order article via Infotrieve]
15. Staessen J, Bulpitt CJ, OBrien E, Cox J, Fagard R, Stanton A, Thijs L, Van Hulle S, Vyncke G, Amery A. The diurnal blood pressure profile: a population study. Am J Hypertens. 1992;5:386-392.[Medline] [Order article via Infotrieve]
16. Contard S, Chanudet X, Coisne D, Battistella P, Marichal JF, Pitiot M, Gaudemaris R, Ribstein J. Ambulatory monitoring of blood pressure in normal pregnancy. Am J Hypertens. 1993;6:880-884.[Medline] [Order article via Infotrieve]
17. Cugini P, Di Palma L, Battisti P, Leone G, Pachi A, Paesano R, Masella C, Stirati G, Pierucci A, Rocca AR, Morabito S. Describing and interpreting 24-hour blood pressure patterns in physiologic pregnancy. Am J Obstet Gynecol. 1992;166:54-60.[Medline] [Order article via Infotrieve]
18. Ferrazzani S, Caruso A, De Carolis S, Pometti A, Tocci A, Mancinelli S, Halberg F, Cornélissen G. Blood pressure monitoring over 24 hours in pregnancy. In: Romanini C, Garzetti GG, Tranquilli AL, Valensise H, eds. Experimental Models in Obstetrics and Gynecology. Carnforth, Lancashire, UK: Parthenon Publishing Group; 1991:113-119.
19. Halligan A, OBrien E, OMalley K, Mee F, Atkins N, Conroy R, Walshe JJ, Darling M. Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J Hypertens. 1993;11:869-873.[Medline] [Order article via Infotrieve]
20. Kyle PM, Clark SJ, Buckley D, Kissane J, Coats AJS, De Swiet M, Redman CWG. Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? Br J Obstet Gynaecol. 1993;100:914-919.[Medline] [Order article via Infotrieve]
21. Margulies M, Zin C, Margulies ND, Voto LS. Noninvasive ambulatory blood pressure control in normotensive pregnant women. Am J Hypertens. 1989;2:924-926.[Medline] [Order article via Infotrieve]
22. Beilin LJ, Deacon J, Michael CA, Vandongen R, Lalor CM, Barden AE, Davidson L. Circadian rhythms of blood pressure and pressor hormones in normal and hypertensive pregnancy. Clin Exp Pharmacol Physiol. 1982;9:321-326.[Medline] [Order article via Infotrieve]
23. Association for the Advancement of Medical Instrumentation. American National Standard for Electronic or Automated Sphygmomanometers. Washington, DC: AAMI; 1987.
24. White WB, Lund-Johansen P, McCabe EJ. Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. J Hypertens. 1989;7:477-483.[Medline] [Order article via Infotrieve]
25. Staessen J, Fagard R, Lijnen P, Thijs L, Vaa Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J Hypertens. 1991;9(suppl 1):s13-s19.
26. Mojón A, Fernández JR, Hermida RC. Chronolab: an interactive software package for chronobiologic time series analysis written for the MacintoshTM computer. Chronobiol Internat. 1992;9:403-412.[Medline] [Order article via Infotrieve]
27. Bingham C, Arbogast B, Cornélissen G, Lee JK, Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia. 1982;9:397-439.[Medline] [Order article via Infotrieve]
28. Fernández JR, Hermida RC. Estimation of population parameters from rhythmometric models with multiple components. Biol Rhythm Res. 1995;26:388. Abstract.
29. 1986 Guidelines for study of mild hypertension. Bull WHO. 1986;64:31-35.[Medline] [Order article via Infotrieve]
30. Mitchell RH, Ruff SC. Computer-aided study of circadian variation of blood pressure in pregnancy. Irish J Med Sci. 1979;148:113.
31. Murnaghan GA. Hypertension in pregnancy. Postgrad Med J. 1976;52(suppl 7):123-196.
32. Redman CWG, Beilin LJ, Bonnar J. Reversed diurnal blood pressure rhythm in hypertensive pregnancies. Clin Sci Mol Med. 1976;51:687s-689s.
33. Hermida RC, Ayala DE, Fernández JR, Fraga JM. Hardware-software approach for neonatal cardiovascular risk estimation. Biomed Instrum Technol. 1994:28:43-51.
34. Croppi E, Livi R, Scarpelli L, Romano S, de Leonardis V, Cagnoni M, Scarpelli PT. Chronobiologically assessed blood pressure (BP) and left ventricular wall thickness in children with and without a family history of high blood pressure. In: Tarquini B, Vergassola R, eds. Social Diseases and Chonobiology. Bologna, Italy: Esculapio; 1986:55-56.
35. Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia, IV: early detection of gestational hypertension and preeclampsia by the computation of a hyperbaric index. J Perinatal Med. 1997;25:254-273.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. T. Mikolajczyk, J. Zhang, J. Ford, and J. Grewal Effects of Interpregnancy Interval on Blood Pressure in Consecutive Pregnancies Am. J. Epidemiol., August 15, 2008; 168(4): 422 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.R.R. Gangula, P. Lanlua, R.D. Bukoski, S.J. Wimalawansa, and C. Yallampalli Mesenteric Arterial Relaxation to Calcitonin Gene-Related Peptide Is Increased During Pregnancy and by Sex Steroid Hormones Biol Reprod, November 1, 2004; 71(5): 1739 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hermida, D. E. Ayala, A. Mojon, J. R. Fernandez, I. Alonso, I. Silva, R. Ucieda, and M. Iglesias Blood Pressure Patterns in Normal Pregnancy, Gestational Hypertension, and Preeclampsia Hypertension, August 1, 2000; 36(2): 149 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hermida, D. E. Ayala, J. R. Fernandez, A. Mojon, I. Alonso, I. Silva, R. Ucieda, J. Codesido, and M. Iglesias Administration Time-Dependent Effects of Aspirin in Women at Differing Risk for Preeclampsia Hypertension, October 1, 1999; 34(4): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tozawa, K. Iseki, S. Yoshi, and K. Fukiyama Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1976 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hermida, D. E. Ayala, A. Mojon, J. R. Fernandez, I. Silva, R. Ucieda, and M. Iglesias Blood Pressure Excess for the Early Identification of Gestational Hypertension and Preeclampsia Hypertension, January 1, 1998; 31(1): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hermida and D. E. Ayala Diagnosing Gestational Hypertension and Preeclampsia With the 24-Hour Mean of Blood Pressure Hypertension, December 1, 1997; 30(6): 1531 - 1537. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |